SARS-CoV-2 immunity

Cell Mol Immunol. 2024 Feb;21(2):101-102. doi: 10.1038/s41423-024-01128-y. Epub 2024 Jan 18.

Author

Antonio Bertoletti¹

Affiliation

¹ Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. antonio@duke-nus.edu.sg.

PMID: 38238439
PMCID: PMC10805843 (available on 2025-02-01)
DOI: 10.1038/s41423-024-01128-y

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Viral
COVID-19*
Humans
SARS-CoV-2

Substances

Antibodies, Viral